Editorial: Recombinant microbes-mediated cancer immunotherapy
Front Immunol
.
2024 Feb 22:15:1386574.
doi: 10.3389/fimmu.2024.1386574.
eCollection 2024.
Authors
Stephen Wechman
1
,
Venkatakrishna Rao Jala
2
,
Luis G Bermudez-Humaran
3
,
Jorge G Gomez-Gutierrez
4
Affiliations
1
Union College, Barbourville, KY, United States.
2
Department of Microbiology and Immunology, University of Louisville, Louisville, KY, United States.
3
National Research Institute for Agriculture, Food and Environment, Jouy-en-Josas, France.
4
Department of Pediatrics, University of Missouri-Columbia, Columbia, MO, United States.
PMID:
38455064
PMCID:
PMC10917935
DOI:
10.3389/fimmu.2024.1386574
No abstract available
Keywords:
cancer; immunotherapy; microbes; recombinant; treatment.
Publication types
Editorial
MeSH terms
Humans
Immunotherapy*
Neoplasms* / therapy
Grants and funding
P30 ES030283/ES/NIEHS NIH HHS/United States